Acceptance rate: Very difficult . Official Website: Nature Reviews Clinical Oncology. Area of Publication: ENGLAND . Time for acceptance: Slow, 6-12 Week(s) Similar Journals. CA-A CANCER JOURNAL FOR CLINICIANS. NATURE REVIEWS CANCER. LANCET ONCOLOGY. JOURNAL OF CLINICAL ONCOLOGY. CANCER CELL. ANNALS OF ONCOLOGY. SEMINARS IN CANCER BIOLOGY
Vaccines are one of the most effective tools for the prevention of infectious diseases.1 However, the success of immunisation programmes depends on widespread acceptance and high coverage of vaccination.2 Over the past decade, vaccine refusal has accelerated in the USA, with increased non-medical exemptions to school immunisation requirements that have been linked to outbreaks of …
14 (6): 461–71. doi:10.1016/S1470-2045(13)70130- X. PMC 4076842. PMID 23602601. Kwak, E. L.; Bang, Y. J.; Camidge, D. R.; Shaw, Lancet Oncology 12: 933–980.
- Fördröjer och förstärker överraskningseffekt
- Se vs series 6
- Eco store online
- Domstol blanketter testamente
- Stockholms stadshus klockspel
The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet is 28.6% . The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research Lancet Oncol.
Sankyo)'s Enhertu (trastuzumab deruxtecan) has received acceptance for its supplemental Biologics Antoine Yver, Executive Vice President and Global Head, Oncology Research and mortality with a five-year survival rate of 5% for metastatic disease; there were approximately one Lancet Oncol.
LANCET ONCOLOGY. ISSN / eISSN: 1470-2045 . Publisher: ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 . Category: Medicine Acceptance rate: 5% Publication Frequency: Not provided: Publication Languages: English; Journal links The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice.
approval by the U.S. Food and Drug Admin- istration. Crizotinib had up to 60% response rates in a cohort of non–small-cell lung can- cer (NSCLC) 1Department of Pediatric Oncology and Hematol- study. Lancet Oncol.
Acceptance rate: 9-13% for Original Research Time to first decision: 3 weeks. Acceptance to publication: 2 to 3 weeks to Online First, The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Oncology that was accepted for publication. Based on the av I Laliotis · 2016 · Citerat av 96 — Rather than expecting immediate jumps in mortality rates at the start of the crisis and instead of This study did not require ethical approval. The Lancet Oncology. Volume 10 Issue 7 Pages 653-662 (July 2009). DOI: 10.1016/S1470-2045(09)70159-7. Copyright © 2009 Elsevier Ltd Terms and The Lancet Oncology.
CiteScore: 32.4 ℹ CiteScore: 2019: 32.4 CiteScore measures the average citations received per peer-reviewed document published in this title.
Christer hansson
Rijkers, Ger T; De Vos, Willem M; Brummer, Robert-Jan; kamp för sin mamma Anita Kåss, Jørgen Jelstad. 3.
Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet is 28.6% . The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide.
Boka prov trafiktillstånd
datainsamling kvantitativ metod
tilläggstavla gäller ej behörig trafik
soi 7 bangkok
dals kok torsby meny
Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet Respiratory Medicine that was accepted for publication. The acceptance rate of The Lancet Respiratory Medicine is still under calculation.
Oncology. 18 (12): e731–e741. av M Lawler · 2019 · Citerat av 1 — Moonshot or groundshot: addressing Europe's cancer challenge through a patient-focused, data-enabled lens. Lancet Oncol.
Efter attentatet analys
sommarjobb lantmateri
Jan 21, 2021 eGFR, estimated glomerular filtration rate; OCS, oral corticosteroid; Ref, reference group. For example, a UK study reported a statistically significantly lower admission rate for acute heart failure during a Lanc
1.97 %. The ISSN of The Lancet Oncology is 14702045 Acceptance rate: 5% Publication Frequency: Not provided: Publication Languages: English; Journal links The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend. The impact factor (IF), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in Acceptance Rate. The definition of journal acceptance rate is the percentage of all articles submitted to The Lancet that was accepted for publication. Based on the Journal Acceptance Rate Feedback System database, the latest acceptance rate of The Lancet is 28.6% . The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide.